153 related articles for article (PubMed ID: 32975920)
21. From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: pathogenic mechanisms of the antiphospholipid syndrome.
Du VX; Kelchtermans H; de Groot PG; de Laat B
Thromb Res; 2013 Sep; 132(3):319-26. PubMed ID: 23958468
[TBL] [Abstract][Full Text] [Related]
22. Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19?
Castillo-Martínez D; Torres Z; Amezcua-Guerra LM; Pineda C
Clin Rheumatol; 2021 Jul; 40(7):3015-3019. PubMed ID: 33826045
[TBL] [Abstract][Full Text] [Related]
23. β
Serrano M; Martínez-Flores JA; Pérez D; García F; Cabrera-Marante O; Pleguezuelo D; Paz-Artal E; Morales JM; González E; Serrano A
Circulation; 2017 May; 135(20):1922-1934. PubMed ID: 28249878
[TBL] [Abstract][Full Text] [Related]
24. Antiphospholipid Syndrome with Antiβ2glicoprotein-1 Antibodies as the Cause of Recurrent Tibial Vein Thrombosis in SAPHO syndrome.
Przepiera-Będzak H; Brzosko M
Acta Dermatovenerol Croat; 2016 Dec; 24(4):305-306. PubMed ID: 28128085
[TBL] [Abstract][Full Text] [Related]
25. Antiphospholipid Antibodies in Critically Ill Patients With COVID-19.
Xiao M; Zhang Y; Zhang S; Qin X; Xia P; Cao W; Jiang W; Chen H; Ding X; Zhao H; Zhang H; Wang C; Zhao J; Sun X; Tian R; Wu W; Wu D; Ma J; Chen Y; Zhang D; Xie J; Yan X; Zhou X; Liu Z; Wang J; Du B; Qin Y; Gao P; Lu M; Hou X; Wu X; Zhu H; Xu Y; Zhang W; Li T; Zhang F; Zhao Y; Li Y; Zhang S
Arthritis Rheumatol; 2020 Dec; 72(12):1998-2004. PubMed ID: 32602200
[TBL] [Abstract][Full Text] [Related]
26. Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein s.
Reverter JC; Tàssies D; Font J; Monteagudo J; Escolar G; Ingelmo M; Ordinas A
Arterioscler Thromb Vasc Biol; 1996 Nov; 16(11):1319-26. PubMed ID: 8911269
[TBL] [Abstract][Full Text] [Related]
27. Antiphospholipid antibodies during infectious mononucleosis and their long term clinical significance.
Ben-Chetrit E; Wiener-Well Y; Fadeela A; Wolf DG
J Clin Virol; 2013 Apr; 56(4):312-5. PubMed ID: 23290387
[TBL] [Abstract][Full Text] [Related]
28. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
[TBL] [Abstract][Full Text] [Related]
29. Laboratory Evaluation of Antiphospholipid Syndrome: An Update on Autoantibody Testing.
Tebo AE
Clin Lab Med; 2019 Dec; 39(4):553-565. PubMed ID: 31668269
[TBL] [Abstract][Full Text] [Related]
30. Interest of IgG and IgM antiprothrombin autoantibodies in the exploration of antiphospholipid syndrome: a 5-year retrospective study.
Bertin D; Beziane A; Resseguier N; Pelissier M; Morange PE; Mege JL; Bardin N
Rheumatology (Oxford); 2020 Jul; 59(7):1539-1544. PubMed ID: 31630203
[TBL] [Abstract][Full Text] [Related]
31. Antiphospholipid antibodies correlate with stroke severity and outcome in patients with antiphospholipid syndrome.
Rodríguez-Sanz A; Martínez-Sánchez P; Prefasi D; Fuentes B; Pascual-Salcedo D; Blanco-Bañares MJ; Díez-Tejedor E
Autoimmunity; 2015; 48(5):275-81. PubMed ID: 25434364
[TBL] [Abstract][Full Text] [Related]
32. Profiles of criteria and non-criteria anti-phospholipid autoantibodies are associated with clinical phenotypes of the antiphospholipid syndrome.
Volkov I; Seguro L; Leon EP; Kovács L; Roggenbuck D; Schierack P; Gilburd B; Doria A; Tektonidou MG; Agmon-Levin N
Auto Immun Highlights; 2020 Dec; 11(1):8. PubMed ID: 32467748
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome.
Zhang S; Wu Z; Li J; Wen X; Li L; Zhang W; Zhao J; Zhang F; Li Y
Clin Rheumatol; 2017 Feb; 36(2):407-412. PubMed ID: 28000012
[TBL] [Abstract][Full Text] [Related]
34. Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
Devreese KMJ; Linskens EA; Benoit D; Peperstraete H
J Thromb Haemost; 2020 Sep; 18(9):2191-2201. PubMed ID: 32619328
[TBL] [Abstract][Full Text] [Related]
35. [Antiphospholipid antibodies in 66 patients with cerebral infarction between 15 and 40 years old].
Siqueira Neto JI; Santos AC; Fábio SR; Sakamoto AC
Arq Neuropsiquiatr; 1996 Dec; 54(4):584-9. PubMed ID: 9201338
[TBL] [Abstract][Full Text] [Related]
36. Correlation between Osteoprotegerin Levels and Antiphospholipid Syndrome Parameters.
Caraiola S; Dima A; Jurcut C; Jurcut R; Baicus C; Baicus A
Lab Med; 2020 Mar; 51(2):193-198. PubMed ID: 31414130
[TBL] [Abstract][Full Text] [Related]
37. Antibodies to phosphatidylserine/prothrombin (aPS/PT) enhanced the diagnostic performance in Chinese patients with antiphospholipid syndrome.
Zhang S; Wu Z; Zhang W; Zhao J; Norman GL; Zeng X; Zhang F; Li Y
Clin Chem Lab Med; 2018 May; 56(6):939-946. PubMed ID: 29561729
[TBL] [Abstract][Full Text] [Related]
38. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
[TBL] [Abstract][Full Text] [Related]
39. Anticardiolipin IgA as a Potential Risk Factor for Pregnancy Morbidity in Patients with Antiphospholipid Syndrome.
Zhai X; Yang S; Cui L
Lab Med; 2022 Sep; 53(5):495-499. PubMed ID: 35640241
[TBL] [Abstract][Full Text] [Related]
40. Presence of Antiphospholipid Antibodies as a Risk Factor for Thrombotic Events in Patients with Connective Tissue Diseases and Idiopathic Thrombocytopenic Purpura.
Habe K; Wada H; Matsumoto T; Ohishi K; Ikejiri M; Matsubara K; Morioka T; Kamimoto Y; Ikeda T; Katayama N; Mizutani H
Intern Med; 2016; 55(6):589-95. PubMed ID: 26984073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
